Douglas J. Manion - 01 Aug 2022 Form 3 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
ACRS
Transactions as of
01 Aug 2022
Net transactions value
$0
Form type
3
Filing time
02 Aug 2022, 17:06:05 UTC
Previous filing
11 Mar 2022
Next filing
03 Feb 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24.1 - Power of Attorney